TipRanks
Go Ultimate55% OFF

Neil F. McFarlane Insider Profile

4 Followers

Neil F. McFarlane, President & CEO, Director at Zevra Therapeutics, holds 417.23K shares in Zevra Therapeutics (Ticker: ZVRA), holds 49.37K shares in Collegium Pharmaceutical (Ticker: COLL), holds 0.00 shares in Adamas Pharmaceuticals (Ticker: ADMS).

Neil F. McFarlane's Trading History

ZVRA
Zevra Therapeutics
Oct 13, 2026President & CEO, DirectorUninformative Buy569.50K$4.29M
COLL
Collegium Pharmaceutical
May 16, 2024DirectorUninformative Buy―$1.17M
ADMS
Adamas Pharmaceuticals
Nov 24, 2021―Uninformative Sell―$0.00
TVTX
Travere Therapeutics
May 16, 2019COOUninformative Sell35.91K$1.36M

You May Also Like

Neil F. McFarlane insider profile FAQ

What stocks does Neil F. McFarlane hold?
Neil F. McFarlane holds: ZVRA, TVTX, ADMS, COLL stocks.
What was Neil F. McFarlane’s latest transaction?
Neil F. McFarlane’s latest transaction was an Uninformative Buy of $569.50K.
What is Neil F. McFarlane's role in Zevra Therapeutics?
Neil F. McFarlane's role in Zevra Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.